Acetylcholinesterase inhibitors associated with lower risk of AMD in Alzheimer’s Disease patients
January 12th 2024Because acetylcholinesterase inhibitors have anti-inflammatory effects, authors of the study wanted to determine if these drugs reduce the risk of AMD in patients with Alzheimer’s disease.
Read More
Kingfisher study: Safety and efficacy of brolucizumab for DME
November 25th 2023The Kingfisher Study found that the visual outcomes after 1 year of brolucizumab, 6 mg, (Beovu, Novartis) in participants with diabetic macular edema (DME) did not differ significantly from those obtained with aflibercept
Read More